Issue 63, 2018

A viable strategy for screening the effects of glycan heterogeneity on target organ adhesion and biodistribution in live mice

Abstract

This work represents the first broad study of testing diverse heterogenous glycoconjugates (7 different glycoalbumins) for their differential in vivo binding (11 different cancer cell types) in both cell- and animal-based studies. As a result, various changes in biodistribution, excretion, and even tumor adhesion were observed.

Graphical abstract: A viable strategy for screening the effects of glycan heterogeneity on target organ adhesion and biodistribution in live mice

Supplementary files

Article information

Article type
Communication
Submitted
24 Feb 2018
Accepted
25 Jun 2018
First published
25 Jun 2018

Chem. Commun., 2018,54, 8693-8696

Author version available

A viable strategy for screening the effects of glycan heterogeneity on target organ adhesion and biodistribution in live mice

A. Ogura, S. Urano, T. Tahara, S. Nozaki, R. Sibgatullina, K. Vong, T. Suzuki, N. Dohmae, A. Kurbangalieva, Y. Watanabe and K. Tanaka, Chem. Commun., 2018, 54, 8693 DOI: 10.1039/C8CC01544A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements